LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

953.91 0.95

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

937.96

Max

958.4

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

1.3B

Verkäufe

3B

106B

KGV

Branchendurchschnitt

26.954

110.024

Dividendenrendite

0.33

Gewinnspanne

1.177

Angestellte

43,000

EBITDA

374M

1.8B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+3.48% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.33%

2.26%

Nächstes Ergebnis

7. Mai 2026

Nächste Dividendenausschüttung

1. Apr. 2026

Nächstes Ex-Dividendendatum

2. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

10B

115B

Vorheriger Eröffnungskurs

952.96

Vorheriger Schlusskurs

953.91

Nachrichtenstimmung

By Acuity

35%

65%

101 / 351 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. Feb. 2026, 22:53 UTC

Akquisitionen, Fusionen, Übernahmen

Keurig Dr Pepper Raises Additional $1.5 Billion in Deal to Split Company

23. Feb. 2026, 22:36 UTC

Ergebnisse

Kratos Defense & Security Solutions 4Q Profit Rises; Sees Federal Shutdown Denting 1Q -- Update

23. Feb. 2026, 22:32 UTC

Ergebnisse

Woodside Energy Fiscal Year Net Profit Falls 24%

23. Feb. 2026, 23:58 UTC

Market Talk
Ergebnisse

Plenty of Questions for Woodside Despite Well-Guided Result -- Market Talk

23. Feb. 2026, 23:58 UTC

Market Talk
Ergebnisse

Global Energy Roundup: Market Talk

23. Feb. 2026, 23:47 UTC

Market Talk

Scentre's Share Price Slips as Earnings Guidance Underwhelms -- Market Talk

23. Feb. 2026, 23:43 UTC

Market Talk

Gold Edges Higher Amid Ongoing Tariff Risks -- Market Talk

23. Feb. 2026, 23:41 UTC

Akquisitionen, Fusionen, Übernahmen

Crescent Capital Partners Owns 53% of ClearView Wealth

23. Feb. 2026, 23:40 UTC

Akquisitionen, Fusionen, Übernahmen

ClearView Wealth Says Crescent Capital Partners Intends to Support Deal

23. Feb. 2026, 23:40 UTC

Akquisitionen, Fusionen, Übernahmen

ClearView Wealth Says Directors Unanimously Recommend Shareholders Vote in Favor of Deal

23. Feb. 2026, 23:40 UTC

Market Talk

Nikkei May Rise as Investors Assess Tariff Developments -- Market Talk

23. Feb. 2026, 23:40 UTC

Akquisitionen, Fusionen, Übernahmen

ClearView Wealth Says Zurich Insurance Offering A$0.65/Share in Cash

23. Feb. 2026, 23:39 UTC

Akquisitionen, Fusionen, Übernahmen

ClearView Wealth Agrees to Takeover by Zurich Insurance Group Unit

23. Feb. 2026, 23:31 UTC

Ergebnisse

United Overseas Bank 2025 Total Dividend S$1.56/Shr >U11.SG

23. Feb. 2026, 23:31 UTC

Ergebnisse

United Overseas Bank Proposes Final Dividend of S$0.71/Shr Vs. S$0.92/Shr >U11.SG

23. Feb. 2026, 23:28 UTC

Ergebnisse

United Overseas Bank 4Q Net Interest Income S$2.35B Vs. S$2.45B >U11.SG

23. Feb. 2026, 23:28 UTC

Ergebnisse

United Overseas Bank 4Q Oper Pft S$1.76B Vs. Pft S$1.88B >U11.SG

23. Feb. 2026, 23:28 UTC

Ergebnisse

United Overseas Bank 4Q Total Income S$3.29B Vs. S$3.46B >U11.SG

23. Feb. 2026, 23:27 UTC

Ergebnisse

United Overseas Bank 4Q Net S$1.41B Vs. Net S$1.52B >U11.SG

23. Feb. 2026, 23:24 UTC

Market Talk

Major Miners On Whole Delivered Positive Earnings Season -- Market Talk

23. Feb. 2026, 22:38 UTC

Akquisitionen, Fusionen, Übernahmen

Keurig Dr Pepper Raises Additional $1.5B in Deal to Split Company

23. Feb. 2026, 22:31 UTC

Ergebnisse

Hims & Hers Stock Falls. Why Earnings Are Underwhelming Investors. -- Barrons.com

23. Feb. 2026, 22:24 UTC

Ergebnisse

Viva Energy Energy & Infrastructure Ebitda A$93 Million

23. Feb. 2026, 22:22 UTC

Ergebnisse

Viva Energy FY Commercial & Industrial Ebitda A$460.5 Million

23. Feb. 2026, 22:22 UTC

Ergebnisse

Viva Energy FY Convenience & Mobility Ebitda A$197.4 Million

23. Feb. 2026, 22:22 UTC

Ergebnisse

Viva Energy FY Underlying Ebitda A$700.9 Million

23. Feb. 2026, 22:22 UTC

Ergebnisse

Viva Energy Final Dividend 3.94 Australian Cents/Security

23. Feb. 2026, 22:21 UTC

Ergebnisse

Viva Energy FY Revenue A$28.53 Billion, Down 1.1%

23. Feb. 2026, 22:21 UTC

Ergebnisse

Viva Energy FY Replacement-Cost Net Profit A$183.6 Million, Down 28%

23. Feb. 2026, 22:20 UTC

Ergebnisse

Viva Energy FY Historical-Cost Net Loss A$421.1 Million

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

3.48% Vorteil

12-Monats-Prognose

Durchschnitt 982.27 USD  3.48%

Hoch 1,107 USD

Tief 885 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

9

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

101 / 351 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat